1280P - nab-paclitaxel (nab-P) + carboplatin (C) induction therapy in patients (Pts) with squamous (SCC) NSCLC: Interim safety results from the phase 3 ABOUND.sqm study

Autor: Vidal, O.J., Daniel, D., Johnson, M., Knoble, J., Chen, T., McCleod, M., Ong, T.J., Trunova, N., Kim, E.
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi444-vi444
Databáze: ScienceDirect